30 Day Trial

Product Launches: Alphatec, DePuy Synthes

Share:

Alphatec launched the IdentiTi™ TLIF Posterior Oblique Titanium Interbody Implant for transforaminal lumbar interbody fusion. The company plans to introduce one more IdentiTi device this year.

For ease of insertion, IdentiTi PO features a self-distracting bulleted nose, smooth medial-lateral surfaces and rounded edges. 

All IdentiTi systems are created through subtractive manufacturing, yielding a consistent porous titanium material with fully interconnected porosity throughout. A proprietary pore structure creates surface roughness for immediate implant stability and surface adhesion. (Source: Alphatec Spine)

 

DePuy Synthes launched the CONDUIT Interbody Platform with EIT Cellular Titanium Technology. The portfolio includes 3D-printed titanium interbody implants with 80% porosity to mimic the 50% to 90% porosity of natural bone.

This is the first series of devices to launch from Johnson & Johnson's 2018 acquisition of Emerging Implant Technologies (EIT). CONDUIT Implants and DePuy Synthes' ACIS ProTi 360° Anterior Cervical Interbody System Hyperlordotic Cages are expected to strengthen the company's interbody cage lineup and contribute to a revenue boost for its spine segment.

CONDUIT implants feature nanoscale surface roughness to support osteoblast adhesion and a modulus of elasticity similar to cancellous bone. (Sources: DePuy Synthes; ORTHOWORLD)

DePuy Synthes CONDUIT Interbody Devices - ORTHOWORLD
DePuy Synthes' CONDUIT Interbody Platform with
EIT Cellular Titanium Technology